Niki BioSolutions
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -825 | -589 | 275 |
Net Income | -307 | -613 | -919 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -535 | -484 | 119 |
Cash | 3,452 | 2,272 | 874 |
Basic Shares | 73 | 72 | 62 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $431 | $1,296 |
Gross Profit | 0 | -255 | 10 | 80 |
EBITDA | -1,817 | -3,756 | -9,476 | -10,317 |
EBIT | -4,011 | -10,601 | -11,525 | |
Net Income | -1,363 | -4,268 | -2,825 | -9,800 |
Net Change In Cash | 0 | 0 | 431 | 1,296 |
Free Cash Flow | -1,836 | -1,189 | -7,727 | -12,505 |
Cash | 3,452 | 874 | 2,005 | 1,882 |
Basic Shares | 73 | 54 | 45 | 35 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.37 |
2025-09-30 | -$0.85 |